Physician profile
Matthew A Kreth
NPI 1750609939
$123,505.96
in general payments reported to CMS, 2019-2025
34 companies · $20K in 2025
The $20K reported for 2025 was more than what 98% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $9,495 · 2021: $1,455 · 2022: $4,179 · 2023: $2,742 · 2024: $58K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Travel and Lodging: $8,427 · Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $59,342.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Travel and Lodging | $8,427.23 |
| Food and Beverage | $3,176.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $71,337.48 | 2022-2025 | Joenja, Ruconest |
| Gilead Sciences, INC. | $38,522.96 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $7,230.28 | 2019-2025 | Trikafta |
| Pari Respiratory Equipment, INC. | $1,627.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $720.33 | 2019-2025 | Tezspire, Fasenra |
| Abbvie INC. | $489.26 | 2019-2025 | |
| Alcresta Therapeutics, INC. | $303.66 | 2022-2024 | Relizorb |
| Genzyme Corporation | $288.34 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $281.77 | 2021-2025 | Dupixent |
| Breas Medical, INC. | $276.52 | 2024-2025 | Vivo 45 Ls |
| Sobi, INC | $261.91 | 2019-2024 | |
| Philips North America LLC | $246.26 | 2020-2022 | |
| Chiesi USA, INC. | $199.36 | 2019-2023 | Bronchitol |
| Glaxosmithkline, LLC. | $154.15 | 2019-2024 | Nucala |
| Fisher & Paykel Healthcare INC | $148.19 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $147.58 | 2019 | |
| Electromed, INC. | $144.35 | 2019-2023 | Smartvest |
| Allergan, INC. | $130.08 | 2019 | |
| Genentech USA, INC. | $113.18 | 2021-2022 | |
| Baxter Healthcare | $112.77 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $108.95 | 2021-2025 | Brinsupri |
| Viatris Specialty LLC | $98.21 | 2025 | Tobi Podhaler |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Mylan Specialty L.P. | $80.56 | 2019-2024 | Tobi Podhaler |
| Advanced Respiratory, INC | $75.14 | 2019-2021 | |
| Amgen INC. | $71.85 | 2021-2022 | |
| 3b Medical, INC. | $66.55 | 2024 | Luna |
| Phadia US INC. | $42.07 | 2021-2022 | |
| Digestive Care, INC. | $35.66 | 2023-2024 | Pertzye |
| Nestle Healthcare Nutrition INC. | $25.97 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $21.21 | 2019 | |
| Monaghan Medical Corporation | $20.71 | 2020 | |
| Vivus LLC | $13.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kreth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.